Abnormal Expression of E-cadherin in Early Gastric Carcinoma: Its Relationship with Macroscopic Growth Patterns and Catenin α and β

Journal of Clinical Gastroenterology

Volumn 38, Issue 3, 2004, Pages 252-259

  Song, Sang Yong ^a   Kim, Seonwoo ^b   Kim, Dae Shick ^a   Son, Hee Jung ^a,b   Rhee, Jong Chul ^a   Kim, Yong Il ^c,d  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Gachon University College of Medicine   (South Korea)

Author keywords

Cadherins; Immunohistochemistry; Pathology; Stomach neoplasms

Indexed keywords

ALPHA CATENIN; BETA CATENIN; MONOCLONAL ANTIBODY; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; TISSUE TYPES; TUMOR VOLUME;

ALPHA CATENIN; BETA CATENIN; CADHERINS; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; STOMACH NEOPLASMS; TRANS-ACTIVATORS;

EID: 1242352560     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200403000-00011     Document Type: Article

References (33)

1. Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol. 1993;119:265-272.
2. Tahara E, Semba S, Tahara H. Molecular biological observations in gastric cancer. Semin Oncol. 1996;23:307-315.
3. Takeichi M. Cadherin cell adhesion receptor as a morphogenetic regulator. Science. 1991;251:1451-1455.
4. Becker KF, Atkinson MJ, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 1994;54:3845-3852.
5. Muta H, Noguchi M, Kanai Y, et al. E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn J Cancer Res. 1996;87:843-848.
6. Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature. 1998;392:402-405.
7. Berx G, Cleton-Jansen AM, Nollet F, et al. E-cadherin is a tumor/ invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 1995;14:6107-6115.
8. Risinger JI, Bershuck A, Kohler MF, et al. Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet. 1994;7:98-102.
9. Shino Y, Watanabe A, Yamada Y, et al. Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas. Cancer. 1995;76:2193-2201.
10. Gabbert HE, Mueller W, Schneiders A, et al. Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer. 1996;69:184-189.
11. Jawhari A, Jordan S, Poole S, et al. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology. 1997;112:46-54.
12. Machado JC, Soares P, Carneiro F, et al. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest. 1999;79:459-465.
13. Ozawa M, Baribault H, Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 1989;8:1711-1717.
14. Ozawa M, Ringwald M, Kemler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of cell adhesion molecule. Proc Natl Acad Sci USA. 1990;87:4246-4250.
15. Hinck L, Nathke IS, Papkoff J, et al. Dynamics of cadherin-catenin complex formation: novel protein interactions and pathways of complex assembly. J Cell Biol. 1994;125:1237-1240.
16. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol. 1993;5:806-811.
17. Yoshiura K, Kanai Y, Ochiai A, et al. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA. 1995;92:7416-7419.
18. Kanai Y, Ushijima S, Hui AM, et al. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer. 1997;71:355-359.
19. Blok P, Craanen ME, Dekker W, et al. Loss of E-cadherin expression in early gastric cancer. Histopathology. 1999;34:410-415.
20. Ohene-Abuakwa Y, Noda M, Perenyi M, et al. Expression of the E-cadherin/catenin (α-, β-, and γ-) complex correlates with the macroscopic appearance of early gastric cancer. J Pathol. 2000;192:433-439.
21. Joo YE, Rew JS, Choi SK, et al. Expression of E-cadherin and catenins in early gastric cancer. J Clin Gastroenterol. 2002;35:35-42.
22. Zhou YN, Xu CP, Han B, et al. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol. 2002;8:987-993.
23. Murakami T. Pathomorphological diagnosis. Definition and gross classification of early gastric cancer. GANN Monogr Cancer. 1971;11:53-55.
24. Xiangming C, Hokita S, Nuruki K, et al. The expression of cadherin-catenin complex in association with the clinicopathologic features of early gastric cancer. Surg Today. 1998;28:587-594.
25. Xiangming C, Hokita S, Natsugoe S, et al. Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer. Oncology. 1999;57:131-137.
26. Cai J, Ikeguchi M, Tsujitani S, et al. Significant correlation between micrometastasis in the lymph nodes and reduced expression of E-cadherin in early gastric cancer. Gastric Cancer. 2001;4:66-74.
27. Shun CT, Wu MS, Lin MT, et al. Immunohistochemical evaluation of cadherin and catenin expression in early gastric carcinomas: correlation with clinicopathologic characteristics and Helicobacter pylori infection. Oncology. 2001;60:339-345.
28. cas) in bladder tumors. Cancer Res. 1996;56:4154-4158.
29. Yonemura Y, Nojima N, Kaji M, et al. E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma. Cancer. 1995;76:941-953.
30. Oka H, Shiozaki H, Kobayashi K, et al. Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Arch A Pathol Anat Histopathol. 1992;421:149-156.
31. Berx G, Becker KF, Hofler H, et al. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat. 1998;14:226-237.
32. Peifer M. Beta-catenin as oncogene: the smoking gun. Science. 1997;275:1752-1753.
33. Jawhari A, Farthing M, Pignatelli M. The importance of the E-cadherin-catenin complex in the maintenance of intestinal epithelial homeostasis: more than intercellular glue? Gut. 1997;41:581-584.